Publication | Closed Access

Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study

OncologyPathologyAdvanced Lung AdenocarcinomaBronchial NeoplasmFirst-line TreatmentCancer TreatmentMedicineRadiation OncologyCancer ResearchLung CancerMolecular OncologyCancer Growth